NHLBI, Qiagen Team Optimizes, Automates qPCR-Based Telomere-Measurement Assay
March 31, 2011
NHLBI, Qiagen Team Optimizes, Automates qPCR-Based Telomere-Measurement Assay
The assay, which its developers claim can measure telomere length in less than half the time of other PCR-based methods while using 20-fold less genetic material, will be deployed as part of a clinical study designed to monitor changes in telomere length in response to certain therapies in patients with telomere diseases.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Bio-Rad, UCSF Lab Develop Droplet Digital PCR Assay for Telomerase Activity
April 18, 2013 / PCR Insider - Qiagen Q4, 2012 Growth Driven Significantly by QiaSymphony Sales in MDx, Applied Markets
January 31, 2013 / PCR Insider - Dx Focus: Clarient to Offer Qiagen Therascreen KRAS Test as Erbitux CDx
January 31, 2013 / PCR Insider - Telome Health Prepares for Q1 2013 Launch of qPCR-Based Telomere Length Test
November 29, 2012 / PCR Insider - Applied Markets News: Qiagen, 3M Tests AOAC Certified; Life Tech's STEC Testing Workflow
July 26, 2012 / PCR Insider